Cowen and Company’s DexCom DXCM Stock Holding History

Cowen and Company’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,355	Closed	-$267K	–	600
2022 Q4	$267K	Sell	2,355 -3,740	-61%	-$411K	0.03%	158
2022 Q3	$491K	Buy	+6,095	New	+$516K	0.05%	122
2022 Q2	–	Sell	-6,256	Closed	-$800K	–	679
2022 Q1	$800K	Buy	6,256 +2,160	+53%	+$236K	0.08%	124
2021 Q4	$550K	Buy	+4,096	New	+$589K	0.05%	212
2021 Q2	–	Sell	-14,284	Closed	-$1.28M	–	618
2021 Q1	$1.28M	Buy	+14,284	New	+$1.34M	0.09%	118

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cowen and Company's DXCM Position: Q1 2023 in Review

Cowen and Company sold out of DexCom (DXCM) in Q1 2023, closing a stake of 2,355 shares — an estimated $267K sold.

Cowen and Company first reported a position in DXCM in Q1 2021 and held it in 5 quarters. The position peaked at $1.28M in Q1 2021. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

Cowen and Company reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
Cowen and Company sold 2,355 DexCom shares in Q1 2023, an estimated $267K.
Cowen and Company first reported a position in DexCom in Q1 2021 and held it in 5 quarters.
Cowen and Company's DexCom position peaked at $1.28M in Q1 2021.
904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.